Risk of Damages Claims and Suspended Transactions Due to Violations of the Act on the Protection of Personal Information
First written in FY2018. 2 of 4 entries say "Restated". Latest entry: FY2021.
0 other companies' latest entry also says "Mitigated".
- FY2021MitigatedAnnual report
「The Group strictly manages operations involving personal or confidential information by identifying the relevant activities and limiting the personnel authorized to handle such information, restricting how it may be handled, and imposing restrictions based on the equipment used.」
The identification of activities involving personal and confidential information, together with restrictions on responsible personnel, handling methods and equipment used, was specified as a response measure. - FY2020RestatedAnnual report
「However, if an incident violating the Act occurs, the Group could face damages lawsuits or suspension of transactions with business partners, which, depending on the circumstances, could affect its business results and financial condition.」
The possibility of damages claims and suspension of transactions in the event of a violation of the Act on the Protection of Personal Information was reconfirmed. - FY2019RestatedAnnual report
「However, if an incident violating the Act occurs, the Group could face damages lawsuits or suspension of transactions with business partners, which, depending on the circumstances, could affect its business results and financial condition.」
The possibility of damages claims and suspension of transactions in the event of a violation of the Act on the Protection of Personal Information was reiterated as an ongoing risk. - FY2018First statedAnnual report
「However, if an incident violating the Act occurs, the Group could face damages lawsuits or suspension of transactions with business partners, which, depending on the circumstances, could affect its business results and financial condition.」
The possibility of damages claims and litigation and suspension of transactions in the event of a violation of the Act on the Protection of Personal Information was identified as a risk associated with transactions with medical institutions.